Table 2 The laboratory profile of patients with primary hepatic angiosarcoma
From: Clinical characteristics and surgical treatments of primary hepatic angiosarcoma
Patient | WBC (109/L) | Hb (g/L) | Plt (109/L) | TBIL (umol/L) | AST/ALT (IU/L) | PT (INR/s) | AFP/CEA/CA19-9 (ng/ml)/(ng/ml)/(U/ml) | Hepatitis B and C | RFLV (%) | ICGR-15(%) |
|---|---|---|---|---|---|---|---|---|---|---|
1 | 8.03 | 145 | 128 | 8.1 | 58/101 | 0.94/12.4 | 5.52/1.4/7.88 | Negative | 70.69 | 2.34 |
2 | 9.44 | 114 | 310 | 10.3 | 46/36 | 0.97/12.8 | 3.77/4.3/22.84 | Negative | 58.13 | 5.32 |
3 | 8.6 | 85 | 233 | 12.4 | 24/31 | 1.18/15.0 | 1.33/0.7/16.92 | Negative | 23.92 | 38.63 |
4 | 6.72 | 127 | 165 | 15.7 | 34/37 | 1.06/13.8 | 1.63/1.4/12.28 | Negative | 31.87 | 31.45 |